Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78


Progesterone inhibits human breast cancer cell growth through transcriptional upregulation of the cyclin-dependent kinase inhibitor p27Kip1 gene.

Gizard F, Robillard R, Gervois P, Faucompré A, Révillion F, Peyrat JP, Hum WD, Staels B.

FEBS Lett. 2005 Oct 24;579(25):5535-41. Epub 2005 Sep 27.


TReP-132 is a novel progesterone receptor coactivator required for the inhibition of breast cancer cell growth and enhancement of differentiation by progesterone.

Gizard F, Robillard R, Gross B, Barbier O, Révillion F, Peyrat JP, Torpier G, Hum DW, Staels B.

Mol Cell Biol. 2006 Oct;26(20):7632-44.


Progesterone regulates transcription of the p21(WAF1) cyclin- dependent kinase inhibitor gene through Sp1 and CBP/p300.

Owen GI, Richer JK, Tung L, Takimoto G, Horwitz KB.

J Biol Chem. 1998 Apr 24;273(17):10696-701.


TReP-132 controls cell proliferation by regulating the expression of the cyclin-dependent kinase inhibitors p21WAF1/Cip1 and p27Kip1.

Gizard F, Robillard R, Barbier O, Quatannens B, Faucompré A, Révillion F, Peyrat JP, Staels B, Hum DW.

Mol Cell Biol. 2005 Jun;25(11):4335-48.


Adenovirus expressing mutant p27kip1 enhanced apoptosis and inhibited the growth of xenografted human breast cancer.

Sasaki T, Katayose Y, Yamamoto K, Mizuma M, Shiraso S, Yabuuchi S, Oda A, Rikiyama T, Oikawa M, Onogawa T, Suzuki M, Lee CT, Unno M.

Surg Today. 2007;37(12):1073-82. Epub 2007 Nov 26.


Ganglioside GM3 modulates tumor suppressor PTEN-mediated cell cycle progression--transcriptional induction of p21(WAF1) and p27(kip1) by inhibition of PI-3K/AKT pathway.

Choi HJ, Chung TW, Kang SK, Lee YC, Ko JH, Kim JG, Kim CH.

Glycobiology. 2006 Jul;16(7):573-83. Epub 2006 Mar 30.


BRCA1 and FOXA1 proteins coregulate the expression of the cell cycle-dependent kinase inhibitor p27(Kip1).

Williamson EA, Wolf I, O'Kelly J, Bose S, Tanosaki S, Koeffler HP.

Oncogene. 2006 Mar 2;25(9):1391-9.


Progesterone induction of the 11beta-hydroxysteroid dehydrogenase type 2 promoter in breast cancer cells involves coordinated recruitment of STAT5A and progesterone receptor to a distal enhancer and polymerase tracking.

Subtil-Rodríguez A, Millán-Ariño L, Quiles I, Ballaré C, Beato M, Jordan A.

Mol Cell Biol. 2008 Jun;28(11):3830-49. doi: 10.1128/MCB.01217-07. Epub 2008 Mar 31.


Integrity of the LXXLL motif in Stat6 is required for the inhibition of breast cancer cell growth and enhancement of differentiation in the context of progesterone.

Wei M, He Q, Yang Z, Wang Z, Zhang Q, Liu B, Gu Q, Su L, Yu Y, Zhu Z, Zhang G.

BMC Cancer. 2014 Jan 8;14:10. doi: 10.1186/1471-2407-14-10.


Activation of protein kinase G Increases the expression of p21CIP1, p27KIP1, and histidine triad protein 1 through Sp1.

Cen B, Deguchi A, Weinstein IB.

Cancer Res. 2008 Jul 1;68(13):5355-62. doi: 10.1158/0008-5472.CAN-07-6869.


SP1-regulated p27/Kip1 gene expression is involved in terbinafine-induced human A431 cancer cell differentiation: an in vitro and in vivo study.

Huang CS, Ho WL, Lee WS, Sheu MT, Wang YJ, Tu SH, Chen RJ, Chu JS, Chen LC, Lee CH, Tseng H, Ho YS, Wu CH.

Biochem Pharmacol. 2008 May 1;75(9):1783-96. doi: 10.1016/j.bcp.2008.02.005. Epub 2008 Feb 13.


Induction of growth arrest and apoptosis in human breast cancer cells by 3,3-diindolylmethane is associated with induction and nuclear localization of p27kip.

Wang Z, Yu BW, Rahman KM, Ahmad F, Sarkar FH.

Mol Cancer Ther. 2008 Feb;7(2):341-9. doi: 10.1158/1535-7163.MCT-07-0476.


Molecular analysis of the p27/kip1 gene in breast cancer.

Tigli H, Buyru N, Dalay N.

Mol Diagn. 2005;9(1):17-21.


Up-regulated p27Kip1 reduces matrix metalloproteinase-9 and inhibits invasion of human breast cancer cells.

Mizuma M, Katayose Y, Yamamoto K, Shiraso S, Sasaki T, Yabuuchi S, Oda A, Masuda K, Rikiyama T, Onogawa T, Ohtsuka H, Motoi F, Egawa S, Unno M.

Anticancer Res. 2008 Sep-Oct;28(5A):2669-77.


Induction of senescence by progesterone receptor-B activation in response to cAMP in ovarian cancer cells.

Takahashi A, Kato K, Kuboyama A, Inoue T, Tanaka Y, Kuhara A, Kinoshita K, Takeda S, Wake N.

Gynecol Oncol. 2009 May;113(2):270-6. doi: 10.1016/j.ygyno.2008.12.032. Epub 2009 Feb 10.


Supplemental Content

Support Center